The Inaugural MedFemTech Congress

Palais des Congres, Paris, France | May 9-10, 2023

Promoting emerging medical solutions for women to improve diagnostics and treatment

Founding Partners

Knowledge Partner

MedFemTech Congress

The inaugural MedFemTech Congress will connect and engage key players in the female medical technology sector, launching a global community of medical professionals, tech visionaries, innovators, investors and other experts from across the health care ecosystem – representing doctors, hospitals, clinics, academia, venture capital firms and technology solution companies.

The overall fem-tech market was valued at $18.7B in 2019 and is projected to reach $60.1B by 2027, with a CAGR of over 15.6%. The industry value remains underestimated.

Over 1,500 companies have been classified as med-fem-tech, categorized into 14 subsectors and 8 aggregated subsectors by application. Of the total market, pregnancy is the largest one.

The inaugural congress will offer a 2-day scientific program focusing on the main medical challenges facing women, primarily highlighting the following topics:

  • Maternal health, prenatal care and breastfeeding
  • Menstrual health
  • Pelvic, sexual organ and other gynecological cancers
  • Reproductive health, assisted reproduction technologies
  • Endometriosis, pelvic floor and sexual health
  • Women’s cancer: breast cancer and reconstruction, ovarian cancer and cervical cancer
  • Menopause and peri- and post-menopausal symptoms
  • Contraception: oral contraceptives and IUDs
  • Gynecological infections: bacterial vaginosis, HPV and sexually transmitted diseases
  • Longevity
  • Diagnostics
  • Artificial intelligence (AI) for women’s health
  • Advanced medicine for women

Each topic will be headlined by a medical presentation and followed by 5-10 brief “lightning talks” by start-ups focusing on their relevant innovation.

The congress will host 50-100 exhibitors with a focus on start-up companies and will offer unique networking opportunities and individual meetings among investors, industry professionals and start-ups.

Forbes “spotlight” articles will provide global exposure for top selected start-ups presented throughout the congress.

We hope to see you in Paris in May 2023 for this innovative event!

Tailored Package for Start-up Companies

$25.1B

Market today

$60.1B

Market projection by 2027

1,500

Start-up companies

Our Unique Structure & Program

Our unique program structure composed of:

Congress Registration

Registration for start-up companies

Tailored Package for Start-up Companies: € 2,000

  • A chance to be selected for a 10-minute presentation, scheduled in the program presenting the company’s innovation

  • 4 complimentary delegate passes

  • Delegate list
  • Access to the congress software to schedule on-site meetings
  • Logo and short company profile on congress website

Additional benefit € 500

  • 6 sqm space provided

Registration for individuals

EARLY REGISTRATION

If registered by 09/03/2023
€ 500

LATE REGISTRATION

If registered by 01/05/2023
€ 650

ONSITE REGISTRATION

From 02/05/2023
€ 750

Registration for industry delegates

EARLY REGISTRATION

If registered by 09/03/2023
€ 800

LATE REGISTRATION

If registered by 01/05/2023
€ 900

ONSITE REGISTRATION

From 02/05/2023
€ 1,000

IMPORTANT:
Once you are registered to the MedFemTech Congress, please note that you agree to receive promotional material and updates regarding the Congress.

Payment
Payment of registration fees can be made through this website using a credit card or by bank transfer.
Payment by bank transfer – all transaction fees should be paid by the registrant.

Cancellation Policy
All cancellations must be faxed, electronically mailed, or postmarked. Refund of registration fees will be as follows:
Postmarked up until March 09, 2023 – 100% refund (minus € 50 handling fee and bank charges)
Postmarked from March 10, 2023 – 50% refund
No refund on cancellations sent after May 1, 2023

Liability
The Congress Secretariat and Organizers cannot accept liability for personal accidents, sickness, and cancellations by any party, nor loss of or damage to private property of participants, either during or directly arising from the MedFemTech Congress.
Participants should make their own arrangements with respect to health and travel insurance.

For further information regarding registration, please contact:
Einat Gassner Gutman
Senior Registration & Accommodation Manager
[email protected]

Founding Members

Prof. Zeev Shoham (IVF-Worldwide)
Prof. Milton Leong (IVF-Worldwide)
Prof. Ran Balicer (Chief Innovation Officer, Clalit Health Services, IL)
Mr. Dominique Busso (Forbes)
Ms. Gila Tolub (McKinsey & Company)
Ms. Marie Busson (McKinsey & Company)
Tiffany Starr McKever (Founder and Chief Strategist, Consensus Healthcare Consultants)

Advisory Board

Maura Rosenfeld, MindUP
Marija Butkovic, Women of Wearables
Navneet Kaur, FemTech India
Reenita Das, Frost & Sullivan

Scientific and Medical Board

Prof. Yesha Sivan, DigitalRosh
Itamar Netzer, MD MBA, OB/GYN, Medical Administration specialist, Clalit
Dr. Stasa Stankovic, University of Cambridge
Noemie Elhadad, PhD, Columbia University
Prof. Jennifer Garrison
Prof. Antonio Pellicer, the ‘IVI Foundation’ and ‘Equipo IVI’
Prof. Gerald Schatten, Pittsburgh Development Center

Partners

Founding Partners

Knowledge Partner

Sponsors

Featured Partners

Participants

Contact Us

VENUE

  • Palais des congress
    Porte Maillot
    Paris, France

Phone

  • + 44-203-582-7735

EMAIL

Industry Liaison

Contact Form

Drop us a line and we’ll get back to you!

The Inaugural MedFemTech Congress

Contact us for more information